Slides and webcasts from ESMO Virtual Plenaries are open to all, ESMO Members and free ESMO Account holders, according to the presenters' agreement to release them.
Login and Watch now!
ESMO Virtual Plenary: October 2021
ADJUVANT ABEMACICLIB COMBINED WITH ENDOCRINE THERAPY (ET): UPDATED RESULTS FROM MONARCHE
- Start date
- 14 Oct 2021
- End date
- 15 Oct 2021
The ESMO Virtual Plenaries are freely available to all healthcare professionals working in Oncology.
The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.
Adjuvant Abemaciclib Combined with Endocrine Therapy (ET): Updated Results from MonarchE
Programme
Thursday, 14 October 2021
19:30-20:30 CEST
Welcome and introduction, Scientific background and context
Nicholas Turner, The Royal Marsden Hospital, London, UK
Adjuvant abemaciclib combined with endocrine therapy (ET): Updated results from monarchE
Joyce O'Shaughnessy, Texas Oncology and US Oncology, Baylor University Medical Center, Dallas, TX, USA
Critical analysis and perspectives
Aditya Bardia, Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA
Discussion and Q&A (i)
Faculty and online audience
Friday, 15 October 2021
13:00-14:10 CEST
(06:00 CDT / 07:00 EDT / 15:00 GST / 19:00 HKT / 20:00 KST / 21:00 AEST)
Virtual Plenary Expert Insights: Webcast of 14 October presentations, Discussion and Q&A (ii)
Faculty and online audience:
Chair: Seock-Ah Im, SNUH - Seoul National University Hospital, Seoul, Republic of Korea
Joyce O'Shaughnessy, Texas Oncology and US Oncology, Baylor University Medical Center, Dallas, TX, USA
Aditya Bardia, Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA
Shaheenah Dawood, Mediclinic City Hospital, Dubai, United Arab Emirates
Richard De Boer, Peter MacCallum Cancer Centre, Melbourne, Australia
Ava Kwong, The University of Hong Kong, Hong Kong, China
